BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14570763)

  • 1. Use of anti-(+)-methamphetamine monoclonal antibody to significantly alter (+)-methamphetamine and (+)-amphetamine disposition in rats.
    Laurenzana EM; Byrnes-Blake KA; Milesi-Hallé A; Gentry WB; Williams DK; Owens SM
    Drug Metab Dispos; 2003 Nov; 31(11):1320-6. PubMed ID: 14570763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of methamphetamine and its metabolite amphetamine in brain and other tissues in rats after intravenous administration.
    Rivière GJ; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1042-7. PubMed ID: 10688621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological effects of two anti-methamphetamine monoclonal antibodies. Supporting data for lead candidate selection for clinical development.
    Laurenzana EM; Stevens MW; Frank JC; Hambuchen MD; Hendrickson HP; White SJ; Williams DK; Owens SM; Gentry WB
    Hum Vaccin Immunother; 2014; 10(9):2638-47. PubMed ID: 25483484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in rats.
    Gentry WB; Laurenzana EM; Williams DK; West JR; Berg RJ; Terlea T; Owens SM
    Int Immunopharmacol; 2006 Jun; 6(6):968-77. PubMed ID: 16644483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with a monoclonal antibody against methamphetamine and amphetamine reduces maternal and fetal rat brain concentrations in late pregnancy.
    White SJ; Hendrickson HP; Atchley WT; Laurenzana EM; Gentry WB; Williams DK; Owens SM
    Drug Metab Dispos; 2014 Aug; 42(8):1285-91. PubMed ID: 24839971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex- and dose-dependency in the pharmacokinetics and pharmacodynamics of (+)-methamphetamine and its metabolite (+)-amphetamine in rats.
    Milesi-Hallé A; Hendrickson HP; Laurenzana EM; Gentry WB; Owens SM
    Toxicol Appl Pharmacol; 2005 Dec; 209(3):203-13. PubMed ID: 15916788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of rats with an anti-(+)-methamphetamine monoclonal antibody shortens the duration of action of repeated (+)-methamphetamine challenges over a one month period.
    Hambuchen MD; Rüedi-Bettschen D; Williams DK; Hendrickson H; Owens SM
    Vaccine; 2014 Oct; 32(47):6213-9. PubMed ID: 25252196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat.
    Rivière GJ; Byrnes KA; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1220-6. PubMed ID: 10565845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic mechanisms of monoclonal antibody-based antagonism of (+)-methamphetamine in rats.
    Byrnes-Blake KA; Laurenzana EM; Carroll FI; Abraham P; Gentry WB; Landes RD; Owens SM
    Eur J Pharmacol; 2003 Feb; 461(2-3):119-28. PubMed ID: 12586207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment of (+)-methamphetamine-induced locomotor effects in rats using one or a combination of two high affinity anti-methamphetamine monoclonal antibodies.
    Hambuchen MD; Rüedi-Bettschen D; Gunnell MG; Hendrickson H; Owens SM
    Hum Vaccin Immunother; 2016 Sep; 12(9):2240-8. PubMed ID: 27163775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestation time-dependent pharmacokinetics of intravenous (+)-methamphetamine in rats.
    White S; Laurenzana E; Hendrickson H; Gentry WB; Owens SM
    Drug Metab Dispos; 2011 Sep; 39(9):1718-26. PubMed ID: 21632964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and preclinical testing of a high-affinity single-chain antibody against (+)-methamphetamine.
    Peterson EC; Laurenzana EM; Atchley WT; Hendrickson HP; Owens SM
    J Pharmacol Exp Ther; 2008 Apr; 325(1):124-33. PubMed ID: 18192498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical characterization of an anti-methamphetamine monoclonal antibody for human use.
    Stevens MW; Tawney RL; West CM; Kight AD; Henry RL; Owens SM; Gentry WB
    MAbs; 2014; 6(2):547-55. PubMed ID: 24492290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination protects rats from methamphetamine-induced impairment of behavioral responding for food.
    Rüedi-Bettschen D; Wood SL; Gunnell MG; West CM; Pidaparthi RR; Carroll FI; Blough BE; Owens SM
    Vaccine; 2013 Sep; 31(41):4596-602. PubMed ID: 23906885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a liquid chromatography-tandem mass spectrometric method for the determination of methamphetamine and amphetamine using small volumes of rat serum.
    Hendrickson HP; Milesi-Hallé A; Laurenzana EM; Owens SM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jul; 806(2):81-7. PubMed ID: 15171915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in methamphetamine pharmacokinetics in adult rats and its transfer to pups through the placental membrane and breast milk.
    Rambousek L; Kacer P; Syslova K; Bumba J; Bubenikova-Valesova V; Slamberova R
    Drug Alcohol Depend; 2014 Jun; 139():138-44. PubMed ID: 24726427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic antagonism of (+)-methamphetamine discrimination by a low-affinity monoclonal anti-methamphetamine antibody.
    McMillan DE; Hardwick WC; Li M; Owens SM
    Behav Pharmacol; 2002 Sep; 13(5-6):465-73. PubMed ID: 12394422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining Active Immunization with Monoclonal Antibody Therapy To Facilitate Early Initiation of a Long-Acting Anti-Methamphetamine Antibody Response.
    Hambuchen MD; Carroll FI; Rüedi-Bettschen D; Hendrickson HP; Hennings LJ; Blough BE; Brieaddy LE; Pidaparthi RR; Owens SM
    J Med Chem; 2015 Jun; 58(11):4665-77. PubMed ID: 25973614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
    O'Neil ML; Kuczenski R; Segal DS; Cho AK; Lacan G; Melega WP
    Synapse; 2006 Nov; 60(6):465-73. PubMed ID: 16897726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity improvement of a therapeutic antibody to methamphetamine and amphetamine through structure-based antibody engineering.
    Thakkar S; Nanaware-Kharade N; Celikel R; Peterson EC; Varughese KI
    Sci Rep; 2014 Jan; 4():3673. PubMed ID: 24419156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.